Latest California Healthline Stories
California Wants to Slash Insulin Prices by Becoming a Drugmaker. Can it Succeed?
Gov. Gavin Newsom proposed spending $100 million to make insulin affordable to millions of people with diabetes under a new state generic drug label, CalRx. But state officials haven’t said how much the insulin will cost patients or how the state will deal with distribution and other challenges.
California quiere producir su propia insulina para bajar su alto costo, ¿lo conseguirá?
La administración del gobernador Gavin Newsom señaló que aproximadamente 4 millones de californianos han sido diagnosticados con diabetes, una enfermedad que puede destruir órganos, la vista y llevar a amputaciones si no se controla. La meta es prevenirlo con insulina más económica.
Taco Bowls and Chicken Curry: Medi-Cal Delivers Ready Meals in Grand Health Care Experiment
California has embarked on an ambitious five-year initiative to improve the health of its sickest Medicaid patients by introducing nontraditional services. In the Inland Empire, where many residents have diabetes, one health plan is diving into the experiment by delivering healthy, prepared meals to those lucky enough to get them.
Tacos y pollo al curry: Medi-Cal ofrece comidas preparadas en un experimento de atención médica
El programa ayuda a personas con diabetes y otras afecciones a comer más sano y a aprender sobre alimentos saludables. Busca mejorar la salud y reducir costos en atención médica.
Journalists Cover the Gamut, From Rising Insulin Costs to Delays in Autism Care for Kids
KHN and California Healthline staff made the rounds on national and local media this week to discuss their stories. Here’s a collection of their appearances.
US Rep. Gaetz’s Diagnosis of What’s Driving Insulin Costs Misses the Root Cause
A diabetes diagnosis is not always related to a person’s weight or overall health, especially for those with Type 1 diabetes, who are dependent on insulin treatment for life.
Journalists Discuss Insulin Costs and Ethical Questions Surrounding a North Carolina Rehab Program
KHN staff made the rounds on national and local media this week to discuss their stories. Here’s a collection of their appearances.
Insulin Copay Cap Passes House Hurdle, But Senate Looks for a Broader Bill
Sens. Susan Collins (R-Maine) and Jeanne Shaheen (D-N.H.) are seeking to craft a compromise that members from both parties could accept. Their plan, still being ironed out, would not guarantee a specific limit on out-of-pocket costs but seeks to roll back insulin prices by barring rebate payments to pharmacy benefit managers.
$35 Insulin Cap Is Welcome, Popular, and Bipartisan. But Congress May Not Pass It Anyway.
Spun off from the ailing but not-quite-dead Build Back Better legislation, a popular proposal to cap out-of-pocket insulin costs at $35 a month faces tough political realities that could kill it.
Fact Check: Biden Sets High Bar in 1st State of the Union Speech
What a difference a year makes. The speech was delivered to a largely unmasked crowd of lawmakers, justices, and Cabinet members in the House chamber.